Kyverna Therapeutics, Inc. Financial Overview
Kyverna Therapeutics, Inc.'s market cap is currently $302.63M. The company's EPS TTM is $-0.85; its P/E ratio is -1.88; Kyverna Therapeutics, Inc. is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.
